Comparison of overall survival and disease-free survival for breast-conserving surgery and mastectomy in breast cancer patients receiving neoadjuvant therapy: a matched case-control study from two institutions
BCS does not affect OS and DFS in BC patients treated with NAT. However, it should be noted that BCS provides a substantial survival benefit as compared to mastectomy in patients with clinically positive lymph nodes and those aged > 40 years.
Authors
- Yue Li (ORCID: https://orcid.org/0000-0002-3964-5645)
- Yueqing Feng
- Senyan Zhang
- Yilu Li
- Xueqian Du
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
- Xinxiang Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fonc.2025.1681937
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peking University First Hospital
- Peking University